United States · 
Who invested in ADARx Pharmaceuticals?
ADARx Pharmaceuticals's investors include BlackRock, Cormorant Asset Management, Vivo Capital, SR One and Lilly Asia Ventures, and 2 more on record.
United States · Venture startup
Who invested in ADARx Pharmaceuticals
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2025, from 1 source
- Latest round
- VentureFeb 2025
- Investors
- 7
The rounds
- Feb 2025VentureAmount undisclosed
Source recorded
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ADARx Pharmaceuticals
How much has ADARx Pharmaceuticals raised?
ADARx Pharmaceuticals has raised 1 round since 2025, none with a disclosed amount.
When did ADARx Pharmaceuticals last raise?
ADARx Pharmaceuticals's most recent round was a Venture in Feb 2025.
Who backed ADARx Pharmaceuticals first?
ADARx Pharmaceuticals's first round on record, in Feb 2025, was backed by BlackRock, Cormorant Asset Management and Vivo Capital and 4 others.
What stage is ADARx Pharmaceuticals at?
ADARx Pharmaceuticals's latest named round is a Venture, in Feb 2025.
Where is ADARx Pharmaceuticals based?
ADARx Pharmaceuticals is based in the United States.
Companies like ADARx Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.